Chan SL, Ryoo BY, Mo F, Chan LL, et al. Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment. J Hepatol 2024 Mar 26:S0168-8278(24)00216-2. doi: 10.1016/j.jhep.2024.
PMID: 38570034